AAAAAA

   
Results: 1-13 |
Results: 13
NOVEL QUINONE ANTIPROLIFERATIVE INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE
Authors: FREW T POWIS G BERGGREN M GALLEGOS A ABRAHAM RT ASHENDEL CL ZALKOW LH HUDSON C GRUSZECKAKOWALIK E BURGESS EM BENEDETTIDOCTOROVICH V KERRIGAN JE LAMBROPOULOS J MERRIMAN R BONJOUKLIAN R
Citation: T. Frew et al., NOVEL QUINONE ANTIPROLIFERATIVE INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE, Anti-cancer drug design, 10(4), 1995, pp. 347-359
INHIBITION OF THE NADH OXIDASE ACTIVITY OF PLASMA-MEMBRANES ISOLATED FROM XENOGRAFTS AND CELL-LINES BY THE ANTITUMOR SULFONYLUREA, N-(4-METHYLPHENYLSULFONYL)-N'-(4-CHLOROPHENYL)UREA (LY-181984) CORRELATES WITHDRUG SUSCEPTIBILITY OF GROWTH
Authors: MORRE DJ MERRIMAN R TANZER LR WU LY MORRE DM MACKELLAR WC
Citation: Dj. Morre et al., INHIBITION OF THE NADH OXIDASE ACTIVITY OF PLASMA-MEMBRANES ISOLATED FROM XENOGRAFTS AND CELL-LINES BY THE ANTITUMOR SULFONYLUREA, N-(4-METHYLPHENYLSULFONYL)-N'-(4-CHLOROPHENYL)UREA (LY-181984) CORRELATES WITHDRUG SUSCEPTIBILITY OF GROWTH, Protoplasma, 184(1-4), 1995, pp. 203-208
ENDOSCOPIC BALLOON SPHINCTEROPLASTY (PAPILLARY DILATION) FOR BILE-DUCT STONES - EFFICACY, SAFETY, AND FOLLOW-UP IN 100 PATIENTS
Authors: MACMATHUNA P WHITE P CLARKE E MERRIMAN R LENNON JR CROWE J
Citation: P. Macmathuna et al., ENDOSCOPIC BALLOON SPHINCTEROPLASTY (PAPILLARY DILATION) FOR BILE-DUCT STONES - EFFICACY, SAFETY, AND FOLLOW-UP IN 100 PATIENTS, Gastrointestinal endoscopy, 42(5), 1995, pp. 468-474
PALLIATION OF ESOPHAGEAL CANCER - EXPERIENCE WITH A EXPANDABLE METAL MESH STENT COMBINED WITH RADIOTHERAPY
Authors: MERRIMAN R MACMATHUNA P CROWE J LENNON J
Citation: R. Merriman et al., PALLIATION OF ESOPHAGEAL CANCER - EXPERIENCE WITH A EXPANDABLE METAL MESH STENT COMBINED WITH RADIOTHERAPY, Gastrointestinal endoscopy, 41(4), 1995, pp. 356-356
ENDOSCOPIC BALLOON SPHINCTEROPLASTY (EBS) REDUCES THE NEED FOR PAPILLOTOMY - 2-YEAR FOLLOW-UP IN 100 PATIENTS
Authors: MACMATHUNA P WHITE P CLARKE E MERRIMAN R LENNON JR CROWE J
Citation: P. Macmathuna et al., ENDOSCOPIC BALLOON SPHINCTEROPLASTY (EBS) REDUCES THE NEED FOR PAPILLOTOMY - 2-YEAR FOLLOW-UP IN 100 PATIENTS, Gastrointestinal endoscopy, 41(4), 1995, pp. 406-406
RETINOBLASTOMA GENE-PRODUCT EXPRESSION IN ESOPHAGEAL CANCER
Authors: CARROLL D RYAN E MULLIGAN E DUGGAN M MERRIMAN R MACMATHUNA P GRAHAM D LENNON J CROWE J
Citation: D. Carroll et al., RETINOBLASTOMA GENE-PRODUCT EXPRESSION IN ESOPHAGEAL CANCER, Gastroenterology, 108(4), 1995, pp. 454-454
RETINOBLASTOMA PROTEIN EXPRESSION BUT NOT P53 PROTEIN EXPRESSION IS PROGNOSTICALLY SIGNIFICANT IN COLORECTAL-CANCER
Authors: RYAN E KITCHING A MERRIMAN R MACMATHUNA P MULLIGAN E DOYCODD MB KELLY P GOREY T LENNON J CROWE J
Citation: E. Ryan et al., RETINOBLASTOMA PROTEIN EXPRESSION BUT NOT P53 PROTEIN EXPRESSION IS PROGNOSTICALLY SIGNIFICANT IN COLORECTAL-CANCER, Gastroenterology, 108(4), 1995, pp. 531-531
ADVANCES WITH PHOSPHOLIPID SIGNALING AS A TARGET FOR ANTICANCER DRUG DEVELOPMENT
Authors: POWIS G BERGGREN M GALLEGOS A FREW T HILL S KOZIKOWSKI A BONJOUKLIAN R ZALKOW L ABRAHAM R ASHENDEL C SCHULTZ R MERRIMAN R
Citation: G. Powis et al., ADVANCES WITH PHOSPHOLIPID SIGNALING AS A TARGET FOR ANTICANCER DRUG DEVELOPMENT, Acta Biochimica Polonica, 42(4), 1995, pp. 395-403
A MULTIWELL ASSAY FOR INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE ANDTHE IDENTIFICATION OF NATURAL PRODUCT INHIBITORS
Authors: FREW T POWIS G BERGGREN M ABRAHAM RT ASHENDEL CL ZALKOW LH HUDSON C QAZIA S GRUSZECKAKOWALIK E MERRIMAN R BONJOUKLIAN R
Citation: T. Frew et al., A MULTIWELL ASSAY FOR INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE ANDTHE IDENTIFICATION OF NATURAL PRODUCT INHIBITORS, Anticancer research, 14(6B), 1994, pp. 2425-2428
ENDOSCOPIC PALLIATION OF ESOPHAGEAL CANCER - EXPERIENCE WITH A NOVEL EXPANDABLE (MICROVASIVE) METAL PROSTHESIS
Authors: MERRIMAN R MACMATHUNA P CROWE J LENNON J
Citation: R. Merriman et al., ENDOSCOPIC PALLIATION OF ESOPHAGEAL CANCER - EXPERIENCE WITH A NOVEL EXPANDABLE (MICROVASIVE) METAL PROSTHESIS, Gastroenterology, 106(4), 1994, pp. 10000414-10000414
DOES CLOSTRIDIUM-DIFFICILE PRECIPITATE OR EXACERBATE INFLAMMATORY BOWEL-DISEASE
Authors: MERRIMAN R MCKEOGH D MACMATHUNA P OKEANE C HONE R LENNON J CROWE J
Citation: R. Merriman et al., DOES CLOSTRIDIUM-DIFFICILE PRECIPITATE OR EXACERBATE INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 106(4), 1994, pp. 10000734-10000734
PROGNOSTIC-SIGNIFICANCE OF RETINOBLASTOMA GENE-PRODUCT EXPRESSION IN COLORECTAL-CANCER
Authors: KITCHING A RYAN E MULLIGAN E MACMATHUNA P MERRIMAN R KELLY P GOREY TF LENNON JR CROWE J
Citation: A. Kitching et al., PROGNOSTIC-SIGNIFICANCE OF RETINOBLASTOMA GENE-PRODUCT EXPRESSION IN COLORECTAL-CANCER, Gastroenterology, 106(4), 1994, pp. 10001032-10001032
THE EFFECT OF THE OXYTOCIN ANTAGONIST ATOSIBAN ON PRETERM UTERINE ACTIVITY IN THE HUMAN
Authors: GOODWIN TM PAUL R SILVER H SPELLACY W PARSONS M CHEZ R HAYASHI R VALENZUELA G CREASY GW MERRIMAN R
Citation: Tm. Goodwin et al., THE EFFECT OF THE OXYTOCIN ANTAGONIST ATOSIBAN ON PRETERM UTERINE ACTIVITY IN THE HUMAN, American journal of obstetrics and gynecology, 170(2), 1994, pp. 474-478
Risultati: 1-13 |